Robert E. Pyke

1.9k total citations
55 papers, 1.4k citations indexed

About

Robert E. Pyke is a scholar working on Psychiatry and Mental health, Clinical Psychology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Robert E. Pyke has authored 55 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 42 papers in Psychiatry and Mental health, 25 papers in Clinical Psychology and 19 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Robert E. Pyke's work include Sexual function and dysfunction studies (39 papers), Sexuality, Behavior, and Technology (23 papers) and Hormonal and reproductive studies (18 papers). Robert E. Pyke is often cited by papers focused on Sexual function and dysfunction studies (39 papers), Sexuality, Behavior, and Technology (23 papers) and Hormonal and reproductive studies (18 papers). Robert E. Pyke collaborates with scholars based in United States, Canada and United Kingdom. Robert E. Pyke's co-authors include Anita H. Clayton, Leonard R. Derogatis, Diane J. Lewis-D’Agostino, Glen Wunderlich, Toshio Kimura, Irwin Goldstein, Miguel García, Evan R. Goldfischer, Martha Greiner and Mark Pierce and has published in prestigious journals such as American Journal of Psychiatry, Biological Psychiatry and Schizophrenia Research.

In The Last Decade

Robert E. Pyke

52 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Robert E. Pyke United States 22 991 518 420 264 168 55 1.4k
Ginés Llorca Spain 11 1.0k 1.0× 375 0.7× 509 1.2× 83 0.3× 64 0.4× 23 1.4k
Beata S. Eisfeld Canada 10 458 0.5× 224 0.4× 240 0.6× 41 0.2× 164 1.0× 12 945
A.M. Ghadirian Canada 19 518 0.5× 265 0.5× 183 0.4× 39 0.1× 135 0.8× 54 1.3k
Chiaki Kawanishi Japan 21 233 0.2× 461 0.9× 52 0.1× 128 0.5× 173 1.0× 76 1.2k
Albert Michael United Kingdom 15 206 0.2× 248 0.5× 104 0.2× 125 0.5× 28 0.2× 34 793
Siow‐Ann Chong Singapore 23 795 0.8× 201 0.4× 85 0.2× 16 0.1× 101 0.6× 43 1.1k
Alexandre González-Rodríguez Spain 19 531 0.5× 311 0.6× 120 0.3× 45 0.2× 44 0.3× 114 1.0k
Z. Zemishlany Israel 17 651 0.7× 377 0.7× 61 0.1× 39 0.1× 94 0.6× 33 1.0k
Marilyn A. Davies United States 13 1.2k 1.2× 452 0.9× 24 0.1× 64 0.2× 195 1.2× 26 1.7k
Zeynep Yılmaz United States 20 370 0.4× 1.1k 2.1× 32 0.1× 123 0.5× 134 0.8× 63 1.5k

Countries citing papers authored by Robert E. Pyke

Since Specialization
Citations

This map shows the geographic impact of Robert E. Pyke's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert E. Pyke with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert E. Pyke more than expected).

Fields of papers citing papers by Robert E. Pyke

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert E. Pyke. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert E. Pyke. The network helps show where Robert E. Pyke may publish in the future.

Co-authorship network of co-authors of Robert E. Pyke

This figure shows the co-authorship network connecting the top 25 collaborators of Robert E. Pyke. A scholar is included among the top collaborators of Robert E. Pyke based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert E. Pyke. Robert E. Pyke is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Pyke, Robert E.. (2021). FDA Decisions on Measures of Hypoactive Sexual Desire Disorder in Women: A History, With Grounds to Consider Clinical Judgment. Sexual Medicine Reviews. 9(2). 186–193. 2 indexed citations
2.
3.
Pyke, Robert E.. (2019). Sexual Performance Anxiety. Sexual Medicine Reviews. 8(2). 183–190. 37 indexed citations
4.
Pyke, Robert E. & Anita H. Clayton. (2019). Lumping, Splitting, and Treating: Therapies Are Needed for Women With Overlapping Sexual Dysfunctions. Sexual Medicine Reviews. 7(4). 551–558. 3 indexed citations
6.
Pyke, Robert E. & Anita H. Clayton. (2018). Effect Size in Efficacy Trials of Women With Decreased Sexual Desire. Sexual Medicine Reviews. 6(3). 358–366. 10 indexed citations
7.
Pyke, Robert E.. (2018). Trazodone in Sexual Medicine: Underused and Overdosed?. Sexual Medicine Reviews. 8(2). 206–216. 15 indexed citations
8.
Clayton, Anita H., David Goldmeier, Rossella E. Nappi, et al.. (2017). Sexual Interest and Desire Inventory—Female. 223–234.
9.
Fisher, William A. & Robert E. Pyke. (2017). Flibanserin Efficacy and Safety in Premenopausal Women With Generalized Acquired Hypoactive Sexual Desire Disorder. Sexual Medicine Reviews. 5(4). 445–460. 17 indexed citations
10.
Pyke, Robert E. & Anita H. Clayton. (2015). Response and Rebuttal to Editorial Comment on “Psychological Treatment Trials for Hypoactive Sexual Desire Disorder: A Sexual Medicine Critique and Perspective”. The Journal of Sexual Medicine. 12(12). 2461–2461. 1 indexed citations
11.
Derogatis, Leonard R., Molly Katz, Michèle Moreau, et al.. (2012). Treatment of Hypoactive Sexual Desire Disorder in Premenopausal Women: Efficacy of Flibanserin in the VIOLET Study. The Journal of Sexual Medicine. 9(4). 1074–1085. 132 indexed citations
12.
Clayton, Anita H., Evan R. Goldfischer, Irwin Goldstein, et al.. (2009). Validation of the Decreased Sexual Desire Screener (DSDS): A Brief Diagnostic Instrument for Generalized Acquired Female Hypoactive Sexual Desire Disorder (HSDD). The Journal of Sexual Medicine. 6(3). 730–738. 135 indexed citations
13.
Clayton, Anita H., Robert Segraves, Sandra R. Leiblum, et al.. (2006). Reliability and Validity of the Sexual Interest and Desire Inventory–Female (SIDI-F), a Scale Designed to Measure Severity of Female Hypoactive Sexual Desire Disorder. Journal of Sex & Marital Therapy. 32(2). 115–135. 110 indexed citations
14.
Pyke, Robert E., et al.. (1999). Pharyngo-oesophageal haemangioma with a positive cough impulse. The Journal of Laryngology & Otology. 113(2). 172–173.
15.
Cowley, Deborah S., et al.. (1996). Effect of CI-988, a cholecystokinin-B receptor antagonist, on lactate-induced panic. Biological Psychiatry. 40(6). 550–552. 10 indexed citations
16.
Pyke, Robert E., et al.. (1996). Analgesic Efficacy of the κ-Receptor Agonist, Enadoline, in Dental Surgery Pain. Clinical Neuropharmacology. 19(1). 92–97. 49 indexed citations
18.
Pyke, Robert E., Neal R. Cutler, Edward E. Schweizer, et al.. (1995). A Double-Blind, Placebo-Controlled Study of a CCK-B Receptor Antagonist, CI-988, in Patients With Generalized Anxiety Disorder. Journal of Clinical Psychopharmacology. 15(6). 428–434. 63 indexed citations
19.
Taylor, Duncan P., et al.. (1991). Phase I trials of BMY 14802, a potential antipsychotic with affinity for sigma binding sites. Schizophrenia Research. 4(3). 327–327. 2 indexed citations
20.
Pyke, Robert E.. (1990). Ear, Nose and Throat Disease. Postgraduate Medical Journal. 66(780). 883–883.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026